CSF parameters associated with early MRI activity in patients with MS
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective To identify CSF parameters at diagnosis of clinically isolated syndrome (CIS) and MS that are associated with early inflammatory disease activity as measured by standardized cerebral MRI (cMRI).
Methods One hundred forty-nine patients with newly diagnosed CIS and MS were included in the retrospective study. cMRI at onset and after 12 months was analyzed for T2 and gadolinium-enhancing lesions. CSF was tested for oligoclonal bands and intrathecal synthesis of immunoglobulin G (IgG), A (IgA), and M (IgM) before initiation of disease-modifying therapy (DMT). In a subgroup of patients, CSF and serum samples were analyzed for sCD27, neurofilament light chain, and IgG subclasses 1 and 3. Association between CSF parameters and cMRI activity was investigated by univariable and multivariable regression analysis in all patients, DMT-treated patients, and untreated patients.
Results IgG index, sCD27 levels in CSF, and to a lesser extent IgM index were associated with the occurrence of new cMRI lesions. IgG index and sCD27 levels in CSF were highly correlated. In a multivariable analysis, IgG index and to a lesser extent IgM index together with DMT treatment status and gender were strongest predictors of future cMRI activity.
Conclusions CSF parameters such as IgG and IgM index are independently associated with future MRI activity and thus might be helpful to support early treatment decisions in patients newly diagnosed with CIS and MS.
Glossary
- AUC=
- area under the curve;
- CIS=
- clinically isolated syndrome;
- cMRI=
- cerebral MRI;
- DMT=
- disease modifying therapy;
- NFL=
- neurofilament;
- OCB=
- oligoclonal band;
- ROC=
- receiver operating characteristic;
- TE=
- echo time;
- TI=
- inversion time;
- TR=
- repetition time
Footnotes
Go to Neurology.org/NN for full disclosures. Funding information is provided at the end of the article.
The Article Processing Charge was funded by the authors.
- Received June 28, 2018.
- Accepted in final form March 21, 2019.
- Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosisCatherina Pfuhl, Ulrike Grittner, René M. Gieß et al.Neurology, September 09, 2019 -
Article
Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MSSinah Engel, Falk Steffen, Timo Uphaus et al.Neurology: Neuroimmunology & Neuroinflammation, February 04, 2020 -
Article
Effects of natalizumab therapy on intrathecal antiviral antibody responses in MSFabienne Largey, Ivan Jelcic, Mireia Sospedra et al.Neurology: Neuroimmunology & Neuroinflammation, September 25, 2019 -
Article
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F.M. Andlauer, Ana Keating et al.Neurology: Neuroimmunology & Neuroinflammation, July 16, 2020